GlassScriptPhysician profile
Susan L Potter
NPI 1336225770
$676.98
in general payments reported to CMS, 2019-2025
14 companies · $91.48 in 2025
The $91.48 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.15 · 2020: $101 · 2021: $28.50 · 2022: $186 · 2023: $122 · 2024: $86.74 · 2025: $91.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $122.16 | 2021-2024 | Azstarys |
| Cranial Technologies, INC | $111.76 | 2019-2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $77.44 | 2022-2023 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $62.03 | 2025 | |
| Merck Sharp & Dohme LLC | $59.95 | 2020-2023 | Vaxneuvance, Vaxelis, M-M-R II |
| Sobi, INC | $56.72 | 2020-2022 | |
| Pfizer INC. | $46.40 | 2019-2024 | |
| Sanofi Pasteur INC. | $35.00 | 2022-2023 | |
| Tris Pharma INC | $31.51 | 2020 | |
| Dermira, INC. | $19.08 | 2019 | |
| Cipher Pharmaceuticals US LLC | $14.86 | 2025 | Natroba, Spinosad |
| Azurity Pharmaceuticals, INC. | $14.59 | 2025 | Alvesco |
| Supernus Pharmaceuticals, INC. | $13.10 | 2022 | |
| Vertical Pharmaceuticals, LLC | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.